Viewing nowLyrica 75 mg (Pregabalin)
Pregabalin 75mg
Hard capsule · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

MFDS item code 201109278 · Notified 2011.10.31 · Insurance code 641605360
Treatment of neuropathic pain, treatment of fibromyalgia, adjunctive treatment of partial-onset seizures in epilepsy
This medication is effective in treating peripheral and central neuropathic pain in adults. In addition, it is used as an adjunct treatment for partial seizures in patients with epilepsy, applicable to both cases with or without secondary general symptoms. Furthermore, it helps alleviate symptoms of fibromyalgia. Therefore, this drug is used to improve symptoms of various neurological disorders.
This medicine is administered orally as pregabalin, with the total daily dose divided into 2 doses, regardless of food. Because this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’) Peripheral neuropathic pain — Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on each patient's response and tolerability, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, it may thereafter be increased at 7-day intervals to a maximum of 600 mg/day. Central neuropathic pain — Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on each patient's response and tolerability, the dose may be increased to 300 mg/day after 1 week. After an additional week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation’) Epilepsy — Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on each patient's response and tolerability, the dose may be increased to 300 mg/day after 1 week. If necessary, it may thereafter be increased at 7-day intervals to a maximum of 600 mg/day. The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg/day. The initial dose is 75 mg twice daily (150 mg/day), and based on efficacy and tolerability, it may be increased to 150 mg twice daily (300 mg/day) within 1 week. For patients who do not experience sufficient benefit at a dose of 300 mg/day, the dose may be increased to 225 mg twice daily (450 mg/day) within 1 week. Clinical studies were also conducted at a dose of 600 mg/day, but there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually over at least 1 week. Dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance (CLcr), (mL/min) ≥60 — Initial dose 150 (mg/day), maximum dose 600 (mg/day), BID or TID Creatinine clearance (CLcr), (mL/min) ≥30 -<60 — Initial dose 75 (mg/day), maximum dose 300 (mg/day), BID or TID Creatinine clearance (CLcr), (mL/min) ≥15 -<30 — Initial dose 25-50 (mg/day), maximum dose 150 (mg/day), QD or BID Creatinine clearance (CLcr), (mL/min) <15 — Initial dose 25 (mg/day), maximum dose 75 (mg/day), QD Supplemental dose after hemodialysis — Initial dose 25, maximum dose 100, single dose b In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose determined according to renal function, a supplemental dose should be administered immediately after each 4-hour hemodialysis session. TID = total daily dose administered in 3 divided doses BID = total daily dose administered in 2 divided doses QD = administered once daily a: The total daily dose (mg/day) should be divided as specified under the method of administration. b: The supplemental dose refers to an additional dose administered once. Dose adjustment is not necessary in patients with hepatic impairment. Older adults (65 years of age or older) — Dose reduction may be necessary in older adults with impaired renal function.
Children under 12 years of age — Administration is not recommended. Adolescent patients aged 12 ~17 years — Administration is not recommended.
This medication may increase the risk of suicidal thoughts or behaviors, so if mood changes or symptoms of depression occur during use, you should immediately inform your healthcare provider. Do not take if you are allergic to any ingredients in this medication or have genetic conditions such as lactose intolerance. Diabetic patients should be cautious as weight gain may require adjustments in blood sugar control medications. If allergic reactions such as angioedema occur, discontinue the medication immediately. Elderly patients are at risk of falls due to dizziness or drowsiness, so they should be particularly careful during initial usage. Temporary blurred vision or changes in vision may occur, so consult your healthcare provider if symptoms arise. Withdrawal symptoms such as insomnia, headache, and anxiety may appear upon discontinuation, so do not stop taking the medication arbitrarily. Due to the risk of drug abuse, patients with psychiatric histories or a history of drug abuse should consult their healthcare provider before taking this medication. Patients with impaired renal function may require dosage adjustments. Patients with heart disease should be cautious when taking this medication. Caution is advised when taking this medication with opioid analgesics due to an increased risk of central nervous system depression. Patients with respiratory or neurological disorders, or the elderly should follow medical advice as they could experience severe respiratory depression. Pregnant women should avoid this medication in early pregnancy due to the risk of fetal malformations, and women of childbearing potential should use effective contraception. Breastfeeding women should consult their healthcare provider about the possibility of this medication passing into breast milk. Dizziness or drowsiness may occur when driving or operating machinery, so avoid these activities until symptoms are confirmed. Severe skin reactions may rarely occur, so discontinue use and consult your healthcare provider if any skin abnormalities arise. In cases of overdose, confusion, drowsiness, and depression may occur, so immediate medical attention is recommended in emergencies. Keep out of reach of children and do not transfer to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air and moisture. It is important to maintain a storage temperature between 15 and 30 degrees Celsius.
A hard capsule with a reddish-brown upper part and a white lower part, containing powder that is white or light yellow in color.
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 75mg
Hard capsule · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.